More Guideline Controversy: The Tricky Business Of Calculating Cardiovascular Risk

Calculating cardiovascular risk has become a central and highly controversial component of cardiovascular guidelines. Now a study in the Annals of Internal Medicine finds that most of the commonly employed tools seriously overestimate the risk of people today.

…

Click here to read the full post on Forbes.